Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI study.
Porta B, Baldassarre D, Camera M, Amato M, Arquati M, Brusoni B, Fiorentini C, Montorsi P, Romano S, Tremoli E, Cortellaro M; MIAMI Study Group. Porta B, et al. Among authors: cortellaro m. Nutr Metab Cardiovasc Dis. 2008 May;18(4):320-8. doi: 10.1016/j.numecd.2007.01.008. Epub 2007 Sep 21. Nutr Metab Cardiovasc Dis. 2008. PMID: 17889518
Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment.
Baldassarre D, Porta B, Camera M, Amato M, Arquati M, Brusoni B, Fiorentini C, Montorsi P, Romano S, Veglia F, Tremoli E, Cortellaro M; MIAMI Study Group. Baldassarre D, et al. Among authors: cortellaro m. Nutr Metab Cardiovasc Dis. 2009 Sep;19(7):481-90. doi: 10.1016/j.numecd.2008.10.003. Epub 2009 Jan 26. Nutr Metab Cardiovasc Dis. 2009. PMID: 19171469 Free article. Clinical Trial.
Target organ damage in a population at intermediate cardiovascular risk, with adjunctive major risk factors: CArdiovascular PREvention Sacco Study (CAPRESS).
Perego F, Renesto E, Arquati M, Scandiani L, Cogliati C, Torzillo D, Zocchi L, Casazza G, Duca P, Chirchiglia S, Lacaita G, Panteghini M, Cortellaro M. Perego F, et al. Among authors: cortellaro m. Intern Emerg Med. 2011 Aug;6(4):337-47. doi: 10.1007/s11739-010-0501-7. Epub 2010 Dec 17. Intern Emerg Med. 2011. PMID: 21165713
Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy).
Lemos PA, Serruys PW, de Feyter P, Mercado NF, Goedhart D, Saia F, Arampatzis CA, Soares PR, Ciccone M, Arquati M, Cortellaro M, Rutsch W, Legrand V. Lemos PA, et al. Among authors: cortellaro m. Am J Cardiol. 2005 Feb 15;95(4):445-51. doi: 10.1016/j.amjcard.2004.10.008. Am J Cardiol. 2005. PMID: 15695126 Free article. Clinical Trial.
114 results